Weed (BUDZ) Other financing activities (2017 - 2018)
Weed (BUDZ) posted quarterly Other financing activities of -$200770.0 for Q4 2018, down 769.23% year-over-year from $30000.0 in Q4 2017, and down 200.0% quarter-over-quarter from $200770.0 in Q1 2018.
Weed (BUDZ) Other financing activities (2017 - 2018) Analysis & Trends
Weed's Other financing activities history runs 2 years deep, the most recent figure standing at -$200770.0 for Q4 2018.
- In Q4 2018, Other financing activities fell 769.23% year-over-year to -$200770.0; the TTM figure through Sep 2019 stood at -$200770.0 (down 187.0% YoY), while the FY2017 annual figure was $30000.0, changed N/A from the prior year.
- Other financing activities for Q4 2018 stood at -$200770.0, down from $200770.0 in the prior quarter.
- The five-year high for Other financing activities was $200770.0 in Q1 2018, with the low at -$200770.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Weed | 3.13 Mn | 3.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -200,770.00 |
| Dec 31, 2018 | -200,770.00 |
| Mar 31, 2018 | 200,770.00 |
| Mar 31, 2018 | 200,770.00 |
| Dec 31, 2017 | 30,000.00 |
| Dec 31, 2017 | 30,000.00 |